🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Video Assisted Study of Salbutamol Response in Viral Wheezing

Recruitingn/aAges 6 Months - 24 MonthsAllUniversity of Oulu
NCT06093152 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is video assisted cross-over study evaluating the effect of inhaled salbutamol in wheeze in children 6-24 months old.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Wheezing * Salbutamol-treatment in emergency department prescribed Exclusion Criteria: * Need for immediate resuscitation * Immediate transfer to ICU * Suspicion of pneumonia based on the auscultation finding * Suspicion of airway foreign body
💊

What it tests

  • Salbutamol
📍

Where

1 site
Department of Pediatrics, Oulu University Hospital
Oulu, Finland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy